(RSEE) Collaborative Investment - Ratings and Ratios
Exchange: BATS • Country: USA • Currency: USD • Type: Etf • ISIN: US19423L5407 • Equity Hedged
RSEE: Equities, ETFs, Stocks, US, International
The Collaborative Investment Series Trust - Rareview Systematic Equity ETF (BATS:RSEE) is an actively managed exchange-traded fund designed to achieve its investment objective by investing in other exchange-traded funds (ETFs) that primarily focus on equity securities. These underlying ETFs provide exposure to a range of global equity markets, including domestic, foreign, and emerging market issuers across various market capitalizations. The funds strategy involves dynamically allocating its investments across four key equity sub-strategies: U.S. Large Capitalization, U.S. Small Capitalization, Emerging Markets, and Non-U.S. Developed Markets securities. This approach allows the fund to adapt to changing market conditions and capitalize on opportunities across different regions and market segments.
As of the latest available data, the fund has an average trading volume of 7,479 shares over the past 20 days, with a last price of $29.11. Its short-term moving averages, such as the 20-day SMA ($29.49) and 50-day SMA ($29.18), suggest modest consolidation in recent trading sessions. The 200-day SMA ($28.39) indicates a longer-term upward trend, with the fund trading above this level. The Average True Range (ATR) of 0.40 reflects relatively low volatility, suggesting stable price movements. The funds assets under management (AUM) stand at $59.75 million, indicating moderate scale and investor interest in its strategy.
3-Month Forecast: Based on the provided technical and fundamental data, the fund is expected to maintain its current trajectory, with potential for slight upside in the near term. The 200-day SMA ($28.39) remains below the current price ($29.11), suggesting continued bullish momentum. However, the narrowing gap between the 20-day ($29.49) and 50-day ($29.18) SMAs may signal a period of consolidation. The low ATR (0.40) suggests that price fluctuations will likely remain muted, with the fund trading within a narrow range. Fundamentally, the AUM of $59.75 million indicates a stable investor base, though further growth in assets could enhance liquidity and potentially improve trading volumes. Overall, the fund is expected to remain range-bound with a slight bullish bias over the next three months.
Additional Sources for RSEE ETF
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
RSEE ETF Overview
Market Cap in USD | 52m |
Category | Equity Hedged |
TER | 1.27% |
IPO / Inception | 2022-01-20 |
RSEE ETF Ratings
Growth Rating | 40.7 |
Fundamental | - |
Dividend Rating | 72.1 |
Rel. Strength | -5.52 |
Analysts | - |
Fair Price Momentum | 26.41 USD |
Fair Price DCF | - |
RSEE Dividends
Dividend Yield 12m | 9.36% |
Yield on Cost 5y | 11.48% |
Annual Growth 5y | 76.15% |
Payout Consistency | 61.1% |
RSEE Growth Ratios
Growth Correlation 3m | -89.1% |
Growth Correlation 12m | 42.9% |
Growth Correlation 5y | 87.5% |
CAGR 5y | 5.41% |
CAGR/Max DD 5y | 0.25 |
Sharpe Ratio 12m | 0.68 |
Alpha | -7.21 |
Beta | 1.193 |
Volatility | 32.38% |
Current Volume | 3.9k |
Average Volume 20d | 10.2k |
As of April 30, 2025, the stock is trading at USD 26.58 with a total of 3,912 shares traded.
Over the past week, the price has changed by +2.88%, over one month by -3.68%, over three months by -9.08% and over the past year by +3.98%.
Partly, yes. Based on ValueRay Analyses, Collaborative Investment (BATS:RSEE) is currently (April 2025) ok to buy, but has to be watched. It has a Growth Technical Rating of 40.71 and therefor an somewhat technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of RSEE as of April 2025 is 26.41. This means that RSEE is currently overvalued and has a potential downside of -0.64%.
Collaborative Investment has no consensus analysts rating.
According to ValueRays Forecast Model, RSEE Collaborative Investment will be worth about 30.2 in April 2026. The stock is currently trading at 26.58. This means that the stock has a potential upside of +13.47%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 30.2 | 13.5% |